
|Videos|November 13, 2020
AAO 2020: Genentech provides update on presentations, product portfolio
Author(s)OT Staff Reports
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Advertisement
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
2
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
3
Ophthalmic drug shortages more frequent, longer lasting than average
4
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
5


































